In a survey of cardiac clinicians, researchers found that neither sex nor race of a patient predicted allocation of HF therapies, although bias was observed in the form of harsher judgment of women overall, particularly for Black women.“Ultimate recommendations for advanced heart therapies differed from a 2019 study that favored transplantation over ventricular assist devices in white men
Endoscopic sleeve gastroplasty was more cost-effective and sustained greater weight loss over 5 years compared with semaglutide for patients with class II obesity, according to…
Websites focused on inhaler technique frequently overlook important preparation steps and device care/maintenance, according to results published in Respiratory Medicine.These findings emphasize the importance of…
After ORBITA-COSMIC, Reducer device’s mechanism of benefit remains unknown
Implementing the recent stronger standard for fine particulate pollution revealed that 131 million Americans breathe unhealthy, polluted air where they live, according to a press…
Patients in rheumatoid arthritis remission who tapered off conventional synthetic disease-modifying antirheumatic drugs had higher risks for flares, with two methods failing to reach non-inferiority…
Vonoprazan was noninferior to high-dose IV proton pump inhibitor therapy in preventing 30-day rebleeding among patients with high-risk peptic ulcer bleeding who had achieved endoscopic…
SAN DIEGO — Researchers have developed a new tool to assess malnutrition in children with end-stage kidney disease to help prevent protein-energy wasting, according…
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Alice T. Epitropoulos, MD, FACS, discusses Vevye, a cyclosporine solution that treats signs and…
In a 3-2 vote, the Federal Trade Commission passed a final rule that bans new noncompete agreements with all workers in for-profit organizations. For existing…
Less than optimal heart health at midlife was associated with a decline in the mental processing speed of Black women, but not white women, researchers…
